|
|
|
* - may be subscription-only |
|
|
- Aclarity: Graduated From Mansfield Bio-Incubator More
- Atavistik Bio: Research Collaboration With Pfizer to
Accelerate Discovery of Novel Precision Allosteric
Therapeutics More
- JCR Pharmaceuticals and Modalis Therapeutics:
Transition to the Next Phase of Joint Research
Agreement for Development of Novel Gene Therapy More
- MilliporeSigma: Acquires HUB Organoids Holding B.V.,
Expands Next-Gen Biology Portfolio More
More
- Neumora Therapeutics: Reports Data From KOASTAL-1
Study of Navacaprant in Major Depressive Disorder More
More
More
More*
- Nona Biosciences: Update on Its Collaborator
DualityBio's Antibody-Drug Conjugate (ADC)
Collaboration With BeiGene More
- Repligen: Launches the CTech SoloVPE PLUS System More
- Takeda: Approval of HYQVIA 10% S.C. (Subcutaneous)
Injection Set in Japan for Patients With
Agammaglobulinemia or Hypogammaglobulinemia More
- Valo Health: Topline Results From Phase 2 SPECTRA
Study of OPL-0401 in Patients With Diabetic
Retinopathy More
More
More*
- Verastem Oncology: FDA Acceptance and Priority
Review of New Drug Application for Avutometinib in
Combination With Defactinib for the Treatment of
Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
More
More*
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Adicet Bio: Inducement Grant Under Nasdaq Listing
Rule 5635(c)(4) More
- Akebia Therapeutics: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Astria Therapeutics: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Bicycle Therapeutics: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- enGene: Inducement Grants Under NASDAQ Listing Rule
5635(c)(4) More
- Hologic: Completes Acquisition of Gynesonics,
Inc. More
- Ikena Oncology and Inmagene Biopharmaceuticals:
Agreement for Merger and Private Placement More
More
More*
More*
- IQHQ Sells Brighton Life Sciences Development Site
for a Loss More*
More*
- Intellia Therapeutics: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- KALA BIO: $10,750,000 Private Placement More
- Life Science Review of 2024: Analyzing
Developments and Planning for Future Success Video
- Mass. Life Sciences Center Ends Angel Investor Tax
Credit Program More*
- Most Important Biotech Stories of 2024: IPOs,
M&A Deals and More Layoffs More*
- Navigating JPM Week 2025: Overcoming Challenges
and Maximizing Value Video
- Once High-Flying, Bluebird Bio Now Faces an
Uncertain Future More*
- Sarepta Therapeutics: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Spyre Therapeutics: Grants of Inducement Awards More
- Syndax Pharmaceuticals: Inducement Grants Under
NASDAQ Listing Rule 5635(c)(4) More
- 10 Biggest Massachusetts Biotech Funding Rounds
of 2024 More*
- The Art of Fundraising - Pre-JPM Partnering Week
Replay Video
- The Definitive Boston Biotech Layoff Tracker for
2024 More*
- TScan Therapeutics: $30 Million Registered Direct
Offering at a 37% Premium More
- Vor Bio: $55.6 Million Private Placement More
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Digital Health Accelerator Seeks Startups for Spring
2025 More*
- 5 FDA Decisions to Watch in the First Quarter of
2025 More
- ICYMI: Interview — Biogen's CEO on Leadership,
People, and Successful Partnerships. More
- Most Notable Massachusetts Drug Approvals of 2024
More*
- Subscribe to LifeSci Startup for Updates on
US Startups More
- Wyss: A Year in Review - 2024 More
|
|
|
|
Section
Sponsor:
|
 |
|
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Boston Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
|
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- (NEW) OPPORTUNITY: Senior Director,
Integrated Marketing & Communications - Remote More
- (NEW) OPPORTUNITY: Clinical Development
Leader - New York, NY More
- (NEW) OPPORTUNITY: Director of Business
Development, Life Sciences - California More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America - Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
